Annual Total Assets
$55.22 M
-$16.64 M-23.16%
31 December 2023
Summary:
Theriva Biologics annual total assets is currently $55.22 million, with the most recent change of -$16.64 million (-23.16%) on 31 December 2023. During the last 3 years, it has risen by +$46.81 million (+556.59%). TOVX annual total assets is now -23.16% below its all-time high of $71.86 million, reached on 31 December 2022.TOVX Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$40.11 M
-$2.28 M-5.38%
01 September 2024
Summary:
Theriva Biologics quarterly total assets is currently $40.11 million, with the most recent change of -$2.28 million (-5.38%) on 01 September 2024. Over the past year, it has dropped by -$21.44 million (-34.83%). TOVX quarterly total assets is now -54.93% below its all-time high of $89.00 million, reached on 01 March 2022.TOVX Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TOVX Total Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -23.2% | -34.8% |
3 y3 years | +556.6% | -43.0% |
5 y5 years | +220.4% | +132.7% |
TOVX Total Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -23.2% | +556.6% | -54.9% | at low |
5 y | 5 years | -23.2% | +556.6% | -54.9% | +456.8% |
alltime | all time | -23.2% | >+9999.0% | -54.9% |
Theriva Biologics Total Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $40.11 M(-5.4%) |
June 2024 | - | $42.39 M(-13.0%) |
Mar 2024 | - | $48.73 M(-11.8%) |
Dec 2023 | $55.22 M(-23.2%) | $55.22 M(-10.3%) |
Sept 2023 | - | $61.55 M(-6.0%) |
June 2023 | - | $65.45 M(-3.6%) |
Mar 2023 | - | $67.89 M(-5.5%) |
Dec 2022 | $71.86 M(+2.1%) | $71.86 M(-8.7%) |
Sept 2022 | - | $78.69 M(-4.4%) |
June 2022 | - | $82.33 M(-7.5%) |
Mar 2022 | - | $89.00 M(+26.5%) |
Dec 2021 | $70.36 M(+736.7%) | - |
Dec 2021 | - | $70.36 M(-6.3%) |
Sept 2021 | - | $75.12 M(-2.8%) |
June 2021 | - | $77.25 M(-2.3%) |
Mar 2021 | - | $79.05 M(+840.0%) |
Dec 2020 | $8.41 M(-51.2%) | $8.41 M(+16.8%) |
Sept 2020 | - | $7.20 M(-24.8%) |
June 2020 | - | $9.58 M(-19.4%) |
Mar 2020 | - | $11.89 M(-31.0%) |
Dec 2019 | $17.23 M(-42.8%) | $17.23 M(-16.9%) |
Sept 2019 | - | $20.74 M(-13.6%) |
June 2019 | - | $24.00 M(-9.9%) |
Mar 2019 | - | $26.63 M(-11.6%) |
Dec 2018 | $30.14 M(+60.0%) | $30.14 M(+179.2%) |
Sept 2018 | - | $10.80 M(+28.2%) |
June 2018 | - | $8.42 M(-32.5%) |
Mar 2018 | - | $12.47 M(-33.8%) |
Dec 2017 | $18.84 M(-16.3%) | $18.84 M(-19.1%) |
Sept 2017 | - | $23.28 M(+47.9%) |
June 2017 | - | $15.74 M(-11.2%) |
Mar 2017 | - | $17.72 M(-21.2%) |
Dec 2016 | $22.50 M(-27.1%) | $22.50 M(+172.8%) |
Sept 2016 | - | $8.25 M(-49.5%) |
June 2016 | - | $16.33 M(-28.2%) |
Mar 2016 | - | $22.74 M(-26.3%) |
Dec 2015 | $30.84 M(+61.1%) | $30.84 M(-27.7%) |
Sept 2015 | - | $42.63 M(+260.2%) |
June 2015 | - | $11.84 M(-13.7%) |
Mar 2015 | - | $13.72 M(-28.4%) |
Dec 2014 | $19.14 M(+17.8%) | $19.14 M(+303.8%) |
Sept 2014 | - | $4.74 M(-49.0%) |
June 2014 | - | $9.29 M(-25.9%) |
Mar 2014 | - | $12.53 M(-22.9%) |
Dec 2013 | $16.26 M(+21.1%) | $16.26 M(+133.8%) |
Sept 2013 | - | $6.95 M(-27.8%) |
June 2013 | - | $9.63 M(-17.6%) |
Mar 2013 | - | $11.68 M(-13.0%) |
Dec 2012 | $13.42 M(+79.5%) | $13.42 M(+130.4%) |
Sept 2012 | - | $5.83 M(-19.6%) |
June 2012 | - | $7.25 M(-13.2%) |
Mar 2012 | - | $8.35 M(+11.7%) |
Dec 2011 | $7.48 M(+81.9%) | $7.48 M(-13.8%) |
Sept 2011 | - | $8.68 M(-8.9%) |
June 2011 | - | $9.52 M(+32.1%) |
Mar 2011 | - | $7.21 M(+75.3%) |
Dec 2010 | $4.11 M | $4.11 M(-12.2%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2010 | - | $4.68 M(+3.4%) |
June 2010 | - | $4.53 M(+38.3%) |
Mar 2010 | - | $3.27 M(-19.7%) |
Dec 2009 | $4.08 M(-44.8%) | $4.08 M(-19.7%) |
Sept 2009 | - | $5.08 M(-11.5%) |
June 2009 | - | $5.73 M(-14.4%) |
Mar 2009 | - | $6.70 M(-9.3%) |
Dec 2008 | $7.39 M(-45.8%) | $7.39 M(-10.0%) |
Sept 2008 | - | $8.21 M(-12.8%) |
June 2008 | - | $9.41 M(-13.2%) |
Mar 2008 | - | $10.84 M(-20.5%) |
Dec 2007 | $13.63 M(+8.9%) | $13.63 M(+46.3%) |
Sept 2007 | - | $9.32 M(-12.8%) |
June 2007 | - | $10.69 M(-7.8%) |
Mar 2007 | - | $11.59 M(-7.4%) |
Dec 2006 | $12.52 M(+769.2%) | $12.52 M(>+9900.0%) |
Sept 2006 | - | $0.00(0.0%) |
June 2006 | - | $0.00(0.0%) |
Mar 2006 | - | $0.00(-100.0%) |
Dec 2005 | $1.44 M(-4.9%) | - |
Mar 2003 | - | $1.24 M(-17.9%) |
Dec 2002 | $1.51 M(-26.3%) | $1.51 M(-15.4%) |
Sept 2002 | - | $1.79 M(-21.8%) |
June 2002 | - | $2.29 M(-1.5%) |
Mar 2002 | - | $2.33 M(+13.1%) |
Dec 2001 | $2.06 M(-62.3%) | $2.06 M(-36.6%) |
Sept 2001 | - | $3.24 M(-7.4%) |
June 2001 | - | $3.50 M(-2.9%) |
Mar 2001 | - | $3.61 M(-33.8%) |
Dec 2000 | $5.45 M(+8.0%) | $5.45 M(+57.2%) |
Sept 2000 | - | $3.47 M(-12.0%) |
June 2000 | - | $3.94 M(-38.1%) |
Mar 2000 | - | $6.36 M(+26.0%) |
Dec 1999 | $5.05 M(+76.4%) | $5.05 M(+215.5%) |
Sept 1999 | - | $1.60 M(-11.1%) |
June 1999 | - | $1.80 M(-21.7%) |
Mar 1999 | - | $2.30 M(-19.7%) |
Dec 1998 | $2.86 M(+308.9%) | $2.86 M(-7.7%) |
Sept 1998 | - | $3.10 M(-48.3%) |
June 1998 | - | $6.00 M(+2900.0%) |
Mar 1998 | - | $200.00 K(-71.4%) |
Dec 1997 | $700.00 K(-75.0%) | $700.00 K(-46.2%) |
Sept 1997 | - | $1.30 M(+18.2%) |
June 1997 | - | $1.10 M(-68.6%) |
Mar 1997 | - | $3.50 M(+25.0%) |
Dec 1996 | $2.80 M(+27.3%) | $2.80 M(-39.1%) |
Sept 1996 | - | $4.60 M(-19.3%) |
June 1996 | - | $5.70 M(+128.0%) |
Mar 1996 | - | $2.50 M(+13.6%) |
Dec 1995 | $2.20 M(+450.0%) | $2.20 M(-33.3%) |
Sept 1995 | - | $3.30 M(+725.0%) |
Dec 1994 | $400.00 K(-77.8%) | $400.00 K(-91.5%) |
Mar 1994 | - | $4.70 M(+161.1%) |
Dec 1993 | $1.80 M | $1.80 M(-37.9%) |
Sept 1993 | - | $2.90 M(-34.1%) |
June 1993 | - | $4.40 M(-12.0%) |
Mar 1993 | - | $5.00 M |
FAQ
- What is Theriva Biologics annual total assets?
- What is the all time high annual total assets for Theriva Biologics?
- What is Theriva Biologics annual total assets year-on-year change?
- What is Theriva Biologics quarterly total assets?
- What is the all time high quarterly total assets for Theriva Biologics?
- What is Theriva Biologics quarterly total assets year-on-year change?
What is Theriva Biologics annual total assets?
The current annual total assets of TOVX is $55.22 M
What is the all time high annual total assets for Theriva Biologics?
Theriva Biologics all-time high annual total assets is $71.86 M
What is Theriva Biologics annual total assets year-on-year change?
Over the past year, TOVX annual total assets has changed by -$16.64 M (-23.16%)
What is Theriva Biologics quarterly total assets?
The current quarterly total assets of TOVX is $40.11 M
What is the all time high quarterly total assets for Theriva Biologics?
Theriva Biologics all-time high quarterly total assets is $89.00 M
What is Theriva Biologics quarterly total assets year-on-year change?
Over the past year, TOVX quarterly total assets has changed by -$21.44 M (-34.83%)